Jack Shireman

680 citations
24 papers · 403 indexed · h-index 12
Topics
Glioma Diagnosis and Treatment (16 papers)Immunotherapy and Immune Responses (5 papers)Neuroinflammation and Neurodegeneration Mechanisms (4 papers)

In The Last Decade

Jack Shireman

20 papers receiving 402 citations

Peers

Jack Shireman
Comparison fields: 5 of 61
  • Molecular Biology 197
  • Genetics 178
  • Immunology 93
  • Oncology 89
  • Cancer Research 86
Replace Seamus P. Caragher with:
Seamus P. Caragher United States
Christin Schmidt Germany
Isabele Cristiana Iser Brazil
Michele Kyle United States
Kristin Stock Germany
Carmen Rapp Germany
Bing Lu-jun China
Diane D. Mao United States
Ilaria Tamagno United States
Olivia Cobb United States
Jack Shireman relative to Seamus P. Caragher United States Seamus P. Caragher's profile →
Citations per field
00.5×1.5×2.3×
Seamus P. Caragher · 1×
Citations per year

Countries citing papers authored by Jack Shireman

Since Specialization
Citations

This map shows the geographic impact of Jack Shireman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Shireman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Shireman more than expected).

Fields of papers citing papers by Jack Shireman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Shireman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Shireman. The network helps show where Jack Shireman may publish in the future.

Co-authorship network of co-authors of Jack Shireman

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Shireman. A scholar is included among the top collaborators of Jack Shireman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Shireman. Jack Shireman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 2
5 0
6 5
7 15
8 18
9 2
10 4
11 9
12 46
13 13
14 20
15 20
16 14
17 60
18 68
19 1
20 44

About Jack Shireman

Jack Shireman is a scholar working on Genetics, Neurology and Immunology, having authored 24 papers that have together received 403 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (16 papers), Immunotherapy and Immune Responses (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). The work is most often cited by research in Genetics (178 citations), Developmental Neuroscience (30 citations) and Neurology (52 citations). Jack Shireman has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include Atique U. Ahmed, Mahua Dey, Shivani Baisiwala, Seamus P. Caragher, Maciej S. Lesniak, C. David James, Fatemeh Atashi, Jason Miska, Gina Lee and Craig Horbinski. Their work appears in journals such as Nature Communications, Journal of Neuroscience and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026